MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.395
-0.005 (-0.36%)
At close: Nov 13, 2026, 4:00 PM EST
1.390
-0.005 (-0.36%)
After-hours: Nov 13, 2026, 4:15 PM EST

MediciNova Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.940.41-1-4.04
Revenue Growth
262.80%-----
Cost of Revenue
0.540.38----
Gross Profit
0.40.03-1-4.04
Selling, General & Admin
6.846.165.485.245.485.72
Research & Development
5.087.157.195.669.148.54
Operating Expenses
11.9213.3112.6810.914.6314.25
Operating Income
-11.53-13.28-12.68-9.9-14.63-10.22
Interest & Investment Income
1.011.31.671.830.810.14
Other Non Operating Income (Expenses)
-0.02-0.01-0.04-0.5-0.25-0.06
Pretax Income
-10.54-11.99-11.04-8.57-14.07-10.13
Income Tax Expense
0.010.010.01000
Net Income
-10.55-12-11.05-8.57-14.07-10.13
Net Income to Common
-10.55-12-11.05-8.57-14.07-10.13
Net Income Growth
------
Shares Outstanding (Basic)
494949494949
Shares Outstanding (Diluted)
494949494949
Shares Change
0.38%0.03%-0.00%0.92%9.42%
EPS (Basic)
-0.21-0.24-0.23-0.17-0.29-0.21
EPS (Diluted)
-0.21-0.24-0.23-0.17-0.29-0.21
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9.8-9.81-10.64-7.45-12.92-9.41
Free Cash Flow Per Share
-0.20-0.20-0.22-0.15-0.26-0.19
Gross Margin
42.24%7.58%-100.00%-100.00%
Operating Margin
-1232.17%-3242.47%--990.03%--253.02%
Profit Margin
-1127.01%-2928.78%--857.15%--251.00%
Free Cash Flow Margin
-1047.68%-2395.41%--745.23%--233.07%
EBITDA
-11.51-13.26-12.65-9.88-14.61-10.19
EBITDA Margin
------252.38%
D&A For EBITDA
0.020.020.020.020.020.03
EBIT
-11.53-13.28-12.68-9.9-14.63-10.22
EBIT Margin
------253.02%
SEC Filings: 10-K · 10-Q